CD4+ T cells and CD8+ T cells have important roles in this process, and especially tumor-infiltrating CD8+ T lymphocytes improve prognosis in several cancers.[23, 24] NLR, PLR and SII may represent these immune response processes and be of prognostic significance.[25, 26]. The gene discussed is CD4; the disease is cancer.